Spring Bank Signs a Research Agreement with the University of Texas Southwestern Medical School to Evaluate STING Antagonist Compounds

Spring Bank Signs a Research Agreement with University of Texas Southwestern Medical School to Evaluate STING Antagonist Compounds

Shots:

  • Spring Bank enters into a collaboration with the University of Texas Southwestern Medical Center for the evaluation of Spring Bank’s STimulator of INterferon Gene (STING) antagonist compounds in autoimmune disease models
  • Spring Bank will evaluate novel STING antagonist compounds in mouse models of autoimmune and inflammatory diseases to meet the unmet medical need for the diseases in which cGAS-STING pathway is dysregulated
  • Spring Bank’s STING antagonist compounds are designed to block aberrant STING-dependent signaling via a novel mechanism of action and being developed for autoimmune diseases including multiple interferonopathies

Click here to­ read full press release/ article | Ref: Spring Bank | Image: Market Beat